New on NPR today. https://www.science.org/doi/
Post# of 148101
https://www.science.org/doi/10.1126/science.abm6131
“In the report the investigators concluded, “In addition to uncovering a critical role of IDO1 in brain glucose metabolism, our study highlights the potential of IDO1 inhibitors, developed as an adjunctive therapy for cancer, to be repurposed for neurodegenerative diseases such as AD.”